Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Diagnostic Test to Develop an AECOPD Identification Tool Through Characteristic Variables Extracted From Diagnosed AECOPD Patients

NCT03556475 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03556475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03556475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Diagnostic Test to Develop an AECOPD Identification Tool Through Characteristic Variables Extracted From Diagnosed AECOPD Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 28, 2020
Completion date
January 18, 2021
Enrollment
300 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute exacerbations of copd